SCHEMBL17636588

SCHEMBL17636588

CCC(C1CCC(c2ccc(O)cc2)(c2ccc(O)cc2)CC1)C(CC)C1CCC(c2ccc(O)cc2)(c2ccc(O)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 9/20 0.48
ESR1 P03372 7/20 0.48
SHBG P04278 2/20 0.40
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
PGR P06401 1/20 0.36
CHRM2 P08172 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
AR P10275 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CHRM1 P11229 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
DRD1 P21728 1/20 0.36
TBXA2R P21731 1/20 0.36
PTGS1 P23219 1/20 0.36
SLC6A2 P23975 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27933495 0.87 ESR2 (0.48) ESR2ESR1LMNACYP1A2PGR
SCHEMBL9066280 0.85 ESR2 (0.47) ESR2ESR1LMNACYP1A2PGR
SCHEMBL17636606 0.83 ESR1 (0.41) ESR2ESR1SHBGLMNACYP1A2
SCHEMBL344470 0.81 ESR2 (0.53) ESR2ESR1CYP2D6OPRM1OPRD1
SCHEMBL28309515 0.81 ESR2 (0.46) ESR2ESR1SLC6A2SLC6A3OPRD1
SCHEMBL17636585 0.80 ESR1 (0.58) ESR2ESR1SHBGLMNAAR
SCHEMBL21232543 0.80 ESR2 (0.41) ESR2ESR1LMNACYP1A2PGR
SCHEMBL7183973 0.79 ESR2 (0.55) ESR2ESR1LMNACYP1A2CYP3A4
SCHEMBL17636601 0.78 RORC (0.42) ESR2ESR1SHBGALOX15
SCHEMBL17636597 0.78 ACHE (0.53) ESR2ESR1SHBGPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9822237-B2 Resin composition, film, polarizing plate protective film, polarizing plate, liquid crystal display device, and bis type alicyclic cardo phenol compound FUJIFILM CORPORATION (JP) 2017-11-21 US disclosed
US-9822237-B2 Resin composition, film, polarizing plate protective film, polarizing plate, liquid crystal display device, and bis type alicyclic cardo phenol compound FUJIFILM CORPORATION (JP) 2017-11-21 US disclosed
US-20160090467-A1 RESIN COMPOSITION, FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND BIS TYPE ALICYCLIC CARDO PHENOL COMPOUND FUJIFILM CORPORATION (JP) 2016-03-31 US disclosed
US-20160090467-A1 RESIN COMPOSITION, FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND BIS TYPE ALICYCLIC CARDO PHENOL COMPOUND FUJIFILM CORPORATION (JP) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160090467-A1 RESIN COMPOSITION, FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE, AND BIS TYPE ALICYCLIC CARDO PHENOL COMPOUND RRS1, XIAP, ARID2 ESR2 1637/4885ESR1 341/4885SHBG 2471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.